What is the treatment for hyperkalemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Hyperkalemia

The treatment for hyperkalemia follows a stepwise approach based on severity, with immediate cardiac membrane stabilization using intravenous calcium, followed by shifting potassium into cells with insulin/glucose and beta-agonists, and ultimately eliminating potassium from the body through diuretics, potassium binders, or hemodialysis. 1, 2

Assessment of Severity

  • Hyperkalemia is classified as mild (5.0-5.9 mEq/L), moderate (6.0-6.4 mEq/L), or severe (≥6.5 mEq/L) 1, 2
  • ECG changes (peaked T waves, flattened P waves, prolonged PR interval, widened QRS) indicate urgent treatment regardless of potassium level 1, 2
  • Severe hyperkalemia (≥6.5 mEq/L) is life-threatening and requires immediate intervention 1

Step 1: Cardiac Membrane Stabilization (Immediate Effect)

  • Administer intravenous calcium to protect the heart from arrhythmias:
    • Calcium chloride (10%): 5-10 mL (500-1000 mg) IV over 2-5 minutes (preferred option) 1, 3
    • OR calcium gluconate (10%): 15-30 mL IV over 2-5 minutes 1, 3
  • Effects begin within minutes but are temporary, lasting only 30-60 minutes 1
  • Important: Calcium does not lower serum potassium but protects against arrhythmias 1
  • Caution: Avoid calcium in patients taking digoxin as it may potentiate digoxin toxicity 3

Step 2: Shift Potassium into Cells (Effect within 15-30 minutes)

  • Administer insulin with glucose:
    • 10 units regular insulin IV with 25g glucose (50 mL of D50W) over 15-30 minutes 1
    • Onset within 15-30 minutes, effect lasts 4-6 hours 1
    • Monitor blood glucose frequently to prevent hypoglycemia 3
  • Nebulized beta-2 agonists:
    • Albuterol: 10-20 mg nebulized over 15 minutes 1
    • Onset within 15-30 minutes, effect lasts 4-6 hours 1
  • Sodium bicarbonate:
    • 50 mEq IV over 5 minutes 1
    • Most effective in patients with concurrent metabolic acidosis 1, 2

Step 3: Eliminate Potassium from Body (Longer-term Effect)

  • Loop diuretics (for patients with adequate renal function):
    • Furosemide: 40-80 mg IV 1
  • Potassium binders:
    • Traditional: Sodium polystyrene sulfonate (Kayexalate): 15-50 g orally or rectally 1, 4
    • Newer agents: Patiromer or sodium zirconium cyclosilicate 1, 5
    • Note: Potassium binders should not be used as emergency treatment for life-threatening hyperkalemia due to delayed onset of action 5, 4
  • Hemodialysis:
    • Most effective method for severe hyperkalemia, especially in patients with renal failure 1, 6
    • Consider when conventional therapies fail 6

IV Fluid Management

  • Normal saline (0.9% NaCl) is the first-line IV fluid for acute hyperkalemia 3
  • Avoid potassium-containing fluids such as Lactated Ringer's 3
  • IV fluids alone are insufficient for treating significant hyperkalemia and must be combined with other potassium-lowering strategies 3

Monitoring During Treatment

  • Check serum potassium levels at 1-2 hour intervals during acute treatment 3
  • Monitor ECG for improvement or worsening 3
  • Watch for rebound hyperkalemia 2-4 hours after treatment 1, 3

Important Clinical Considerations

  • Temporary measures (insulin/glucose, albuterol) provide only transient effects (1-4 hours) 1
  • Rebound hyperkalemia can occur after 2 hours 1
  • Review and adjust medications that may contribute to hyperkalemia (ACE inhibitors, ARBs, MRAs, NSAIDs, beta-blockers) 1, 2
  • For chronic hyperkalemia management, consider newer potassium binders like patiromer 5, 7

Special Populations

  • Pediatric dosing:
    • Calcium chloride: 20 mg/kg (0.2 mL/kg for 10% CaCl₂) 1
    • Insulin: 0.1 unit/kg with 400 mg/kg glucose 3
  • Patients with malignant hyperthermia: Use calcium only in extreme cases as it may contribute to calcium overload 2

References

Guideline

Immediate Treatment for Hyperkalemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hyperkalemia Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hyperkalemia with IV Fluids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.